User:Natalya Boufan/Sandbox 1
From Proteopedia
< User:Natalya Boufan(Difference between revisions)
(21 intermediate revisions not shown.) | |||
Line 3: | Line 3: | ||
== Introduction == | == Introduction == | ||
- | '''Isocitrate dehydrogenase kinase/phosphatase (IDHK/P or AceK)''' is an E. coli enzyme which phosphorylates or dephosphorylates [http://proteopedia.org/wiki/index.php/IDH isocitrate dehydrogenase (IDH)] on a specific serine residue (<scene name='78/783138/Ser113/5'>Ser113</scene>) thus regulating its activities. This is a regulatory mechanism which enables bacteria to bypass the Krebs cycle via the glyoxylate shunt in response to nutrient availability. AceK is expressed from a single gene, aceK. Both kinase and phosphatase activities reside on the same polypeptide and share the same active sites<ref name="laporte">PMID:2557093 | + | '''Isocitrate dehydrogenase kinase/phosphatase (IDHK/P or AceK)''' is an E. coli enzyme which phosphorylates or dephosphorylates [http://proteopedia.org/wiki/index.php/IDH isocitrate dehydrogenase (IDH)] on a specific serine residue (<scene name='78/783138/Ser113/5'>Ser113</scene>) thus regulating its activities. This is a regulatory mechanism which enables bacteria to bypass the Krebs cycle via the glyoxylate shunt in response to nutrient availability<ref name="cozzone">DOI:10.1146/annurev.micro.52.1.127</ref> (see also: [[Krebs cycle importance]]). AceK is expressed from a single gene, aceK. Both kinase and phosphatase activities reside on the same polypeptide and share the same active sites<ref name="laporte">PMID:2557093</ref>. |
= Structure<ref name="zheng">doi:10.1038/nature09088</ref> = | = Structure<ref name="zheng">doi:10.1038/nature09088</ref> = | ||
- | The AceK structure contains two functional domains: a Kinase domain (KD) where the kinase, phosphatase and ATPase reactions occur, and a regulatory (RD) that helps form allosteric binding pockets involved in regulating the catalytic domain’s function. The <scene name='78/783138/Amp_binding/ | + | The AceK structure contains two functional domains: a Kinase domain (KD) where the kinase, phosphatase and ATPase reactions occur, and a regulatory (RD) that helps form allosteric binding pockets involved in regulating the catalytic domain’s function. The <scene name='78/783138/Amp_binding/8'>AMP molecule</scene>, is situated in a pocket at the interface between the KD and RD and acts as a bridge. |
The <scene name='78/783138/Regulation_domain/4'>regulatory domain</scene>, which comprises the amino-terminal half of the AceK sequence, is mainly composed of a-helices and hairpin structures.This domain represents a unique protein fold with no structural homologues. The regulatory domain is linked to the kinase domain by a 27-residue-long a-helix. The <scene name='78/783138/Kinase_domain/13'>kinase domain</scene>, which makes up the carboxy-terminal half of AceK, has a classic bi-lobe protein kinase fold with the <scene name='78/783138/Atp_binding_site/1'>ATP-binding cleft</scene> located at the interface between the two lobes. The N-terminal lobe consists mainly of a twisted, five-stranded, antiparallel b-sheet and two a-helices. The larger C-terminal lobe is predominantly a-helical with some stretches of antiparallel b-strands. The ATP molecule is under the cover of the five-stranded b-sheet and is shielded by <scene name='78/783138/Loopb/3'>loop-b3aC</scene>. Loop-b3aC shifts upwards or downwards to controls access to the ATP-binding site. The <scene name='78/783138/Srl/1'>substrate recognition loop</scene> (SRL) stretches out of the C-terminal lobe. This loop, together with loop-b3aC, forms a large cleft that is the <scene name='78/783138/Icdh_binding_cleft/1'>IDH binding site</scene>. | The <scene name='78/783138/Regulation_domain/4'>regulatory domain</scene>, which comprises the amino-terminal half of the AceK sequence, is mainly composed of a-helices and hairpin structures.This domain represents a unique protein fold with no structural homologues. The regulatory domain is linked to the kinase domain by a 27-residue-long a-helix. The <scene name='78/783138/Kinase_domain/13'>kinase domain</scene>, which makes up the carboxy-terminal half of AceK, has a classic bi-lobe protein kinase fold with the <scene name='78/783138/Atp_binding_site/1'>ATP-binding cleft</scene> located at the interface between the two lobes. The N-terminal lobe consists mainly of a twisted, five-stranded, antiparallel b-sheet and two a-helices. The larger C-terminal lobe is predominantly a-helical with some stretches of antiparallel b-strands. The ATP molecule is under the cover of the five-stranded b-sheet and is shielded by <scene name='78/783138/Loopb/3'>loop-b3aC</scene>. Loop-b3aC shifts upwards or downwards to controls access to the ATP-binding site. The <scene name='78/783138/Srl/1'>substrate recognition loop</scene> (SRL) stretches out of the C-terminal lobe. This loop, together with loop-b3aC, forms a large cleft that is the <scene name='78/783138/Icdh_binding_cleft/1'>IDH binding site</scene>. | ||
+ | |||
+ | = Active Site = | ||
+ | A <scene name='78/783138/Catalytic_triad/3'>catalytic triad</scene> is present in AceK, involving residues Asp457, Asn462 and Asp475, in the ATP binding region<ref name="yates"/>. Asp477 and Asp475 interact with the g-phosphate of ATP, and Asp475 coordinates the ATP-liganded single magnesium ion. This signature motif is crucial for the kinase activity<ref name="zheng"/>. <scene name='78/783138/Lys461/2'>Lys461</scene> interacts with ATP and Ser113, playing a significant role in binding of the reactants and keeping them in close contact conformation. <scene name='78/783138/Lys336/3'>Lys336</scene>, a key residue for ATP binding, is holding ATP in proper conformation through electrostatic interactions. | ||
+ | Analysis of the structural change along with calculated reaction pathway suggests that catalytic reaction of phosphotransfer process is a dissociative mechanism<ref>doi:10.1371/journal.pone.0072048</ref>. In addition, theoretical calculations and experiments suggest that a phosphatase reaction follows a general acid–base catalysis associative mechanism in a stepwise mode<ref name="wang">DOI:10.1039/c4cc05375c</ref>. It is expected that more research will be done to gain more insights. | ||
= Function = | = Function = | ||
AceK monitors general metabolism by responding to the levels of a wide variety of metabolites. This ability of AceK allows the IDH phosphorylation cycle to compensate for substantial perturbations of the system<ref name="laporte"/>. When a less preferred carbon source is available, the cell responds by phosphorylating IDH, thus inactivating IDH and activating the glyoxylate bypass<ref name="cozzone"/>. Many of the regulatory effectors are derived from the end products of the glyoxylate bypass, and represent negative feedback inhibition mechanisms<ref name="yates">doi:10.1098/rstb.2011.0426</ref>. | AceK monitors general metabolism by responding to the levels of a wide variety of metabolites. This ability of AceK allows the IDH phosphorylation cycle to compensate for substantial perturbations of the system<ref name="laporte"/>. When a less preferred carbon source is available, the cell responds by phosphorylating IDH, thus inactivating IDH and activating the glyoxylate bypass<ref name="cozzone"/>. Many of the regulatory effectors are derived from the end products of the glyoxylate bypass, and represent negative feedback inhibition mechanisms<ref name="yates">doi:10.1098/rstb.2011.0426</ref>. | ||
- | Furthermore, Depletion in AMP levels signals that the cell requires energy and isocitrate will continue through the Krebs cycle with IDH dephosphorylated<ref name="yates"/>.AMP binds directly to AceK, activate IDH phosphatase and inhibit both IDH kinase and the intrinsic ATPase activities<ref>PMID:10625615</ref>. An AMP-mediated conformational change exposes and shields ATP, acting as a switch between AceK kinase and phosphatase activities, and IDH-binding induces further conformational change for AceK activation. During the activation SRL of the kinase domain recognizes the IDH active cleft and inserts into a binding pocket formed by the | + | Furthermore, Depletion in AMP levels signals that the cell requires energy and isocitrate will continue through the Krebs cycle with IDH dephosphorylated<ref name="yates"/>.AMP binds directly to AceK, activate IDH phosphatase and inhibit both IDH kinase and the intrinsic ATPase activities<ref>PMID:10625615</ref>. An AMP-mediated conformational change exposes and shields ATP, acting as a switch between AceK kinase and phosphatase activities, and IDH-binding induces further conformational change for AceK activation. During the activation SRL of the kinase domain recognizes the IDH active cleft and inserts into a binding pocket formed by the IDH dimer, yielding strict substrate specificity and triggering substrate conformational change for catalysis which allow the <scene name='78/783138/Ser113/5'>Ser113</scene> residue be more accessible for AceK<ref name="zheng"/>. |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
= Relevance = | = Relevance = | ||
- | + | AceK is a unique bifunctional enzyme possessing two opposing activities. The enzyme represents the first case in which a typical eukaryotic | |
- | + | protein kinase scaffold possesses phosphatase activity. Furthermore, the kinase, phosphatase and ATPase activities all share the same active site, leading to the suggestion that the IDH phosphatase function is a mere reversal of its kinase mechanism<ref name="wang"/>. Moreover, the AceK complex structure illustrates a highly specific recognition and intimate interaction between the enzyme and the substrate. It requires not only the tertiary structure of the substrate but also its dimer for recognition and binding<ref name="zheng"/>. An additional distinct characteristic of AceK is the presence of only one Mg2+ ion in the active site whereas, in general, protein phosphatases usually contain two or more metal ions. The establishment of the working model of AceK provides a crucial foundation for further understanding its essential role in helping microorganisms cope with environmental stress<ref name="wang"/>. | |
- | + | ||
- | + | ||
</StructureSection> | </StructureSection> | ||
+ | == 3D structures of Isocitrate dehydrogenase kinase/phosphatase == | ||
+ | *[[3lc6]], [[3eps]] – EcIDHK/P+ADP+AMP+Mg - ''Escherichia coli''<br /> | ||
+ | *[[3lcb]] – EcIDHK/P+EcIDH+ADP+AMP+Mg<br /> | ||
+ | *[[4p69]] - EcIDHK/P (mutant) + IDH<br /> | ||
== References == | == References == | ||
<references/> | <references/> |
Current revision
Isocitrate dehydrogenase kinase/phosphatase
|
3D structures of Isocitrate dehydrogenase kinase/phosphatase
- 3lc6, 3eps – EcIDHK/P+ADP+AMP+Mg - Escherichia coli
- 3lcb – EcIDHK/P+EcIDH+ADP+AMP+Mg
- 4p69 - EcIDHK/P (mutant) + IDH
References
- ↑ 1.0 1.1 Cozzone AJ. Regulation of acetate metabolism by protein phosphorylation in enteric bacteria. Annu Rev Microbiol. 1998;52:127-64. doi: 10.1146/annurev.micro.52.1.127. PMID:9891796 doi:http://dx.doi.org/10.1146/annurev.micro.52.1.127
- ↑ 2.0 2.1 Laporte DC, Stueland CS, Ikeda TP. Isocitrate dehydrogenase kinase/phosphatase. Biochimie. 1989 Sep-Oct;71(9-10):1051-7. PMID:2557093
- ↑ 3.0 3.1 3.2 3.3 Zheng J, Jia Z. Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase. Nature. 2010 Jun 17;465(7300):961-5. Epub 2010 May 26. PMID:20505668 doi:10.1038/nature09088
- ↑ 4.0 4.1 4.2 Zheng J, Yates SP, Jia Z. Structural and mechanistic insights into the bifunctional enzyme isocitrate dehydrogenase kinase/phosphatase AceK. Philos Trans R Soc Lond B Biol Sci. 2012 Sep 19;367(1602):2656-68. doi:, 10.1098/rstb.2011.0426. PMID:22889914 doi:http://dx.doi.org/10.1098/rstb.2011.0426
- ↑ Li Q, Zheng J, Tan H, Li X, Chen G, Jia Z. Unique kinase catalytic mechanism of AceK with a single magnesium ion. PLoS One. 2013 Aug 19;8(8):e72048. doi: 10.1371/journal.pone.0072048. eCollection, 2013. PMID:23977203 doi:http://dx.doi.org/10.1371/journal.pone.0072048
- ↑ 6.0 6.1 6.2 Wang S, Shen Q, Chen G, Zheng J, Tan H, Jia Z. The phosphatase mechanism of bifunctional kinase/phosphatase AceK. Chem Commun (Camb). 2014 Nov 25;50(91):14117-20. doi: 10.1039/c4cc05375c. PMID:25272278 doi:http://dx.doi.org/10.1039/c4cc05375c
- ↑ Miller SP, Chen R, Karschnia EJ, Romfo C, Dean A, LaPorte DC. Locations of the regulatory sites for isocitrate dehydrogenase kinase/phosphatase. J Biol Chem. 2000 Jan 14;275(2):833-9. PMID:10625615